Absorption of 5G radiation in brain tissue as a function of frequency, power and time

The rapid release of 5G wireless communications networks has spurred renewed concerns regarding the interactions of higher radiofrequency (RF) radiation with living species. We examine RF exposure and absorption in ex vivo bovine brain tissue and a brain simulating gel at three frequencies: 1.9 GHz, 4 GHz and 39 GHz that are relevant to current (4G), and upcoming (5G) spectra. We introduce a highly sensitive thermal method for the assessment of radiation exposure, and derive experimentally, accurate relations between the temperature rise (ΔT), specific absorption rate (SAR) and the incident power density (F), and tabulate the coefficients, ΔT/ΔF and Δ(SAR)/ΔF , as a function of frequency, depth and time. This new method provides both ΔT and SAR applicable to the frequency range below and above 6 GHz as shown at 1.9, 4 and 39 GHz, and demonstrates the most sensitive experimental assessment of brain tissue exposure to millimeter-wave radiation to date, with a detection limit of 1 mW. We examine the beam penetration, absorption and thermal diffusion at representative 4G and 5G frequencies and show that the RF heating increases rapidly with frequency due to decreasing RF source wavelength and increasing power density with the same incident power and exposure time. We also show the temperature effects of continuous wave, rapid pulse sequences and single pulses with varying pulse duration, and we employ electromagnetic modeling to map the field distributions in the tissue. Finally, using this new methodology, we measure the thermal diffusivity of ex vivo bovine brain tissue experimentally

Absorption of 5G radiation in brain tissue as a function of frequency, power and time

The rapid release of 5G wireless communications networks has spurred renewed concerns regarding the interactions of higher radiofrequency (RF) radiation with living species. We examine RF exposure and absorption in ex vivo bovine brain tissue and a brain simulating gel at three frequencies: 1.9 GHz, 4 GHz and 39 GHz that are relevant to current (4G), and upcoming (5G) spectra. We introduce a highly sensitive thermal method for the assessment of radiation exposure, and derive experimentally, accurate relations between the temperature rise (ΔT), specific absorption rate (SAR) and the incident power density (F), and tabulate the coefficients, ΔT/ΔF and Δ(SAR)/ΔF , as a function of frequency, depth and time. This new method provides both ΔT and SAR applicable to the frequency range below and above 6 GHz as shown at 1.9, 4 and 39 GHz, and demonstrates the most sensitive experimental assessment of brain tissue exposure to millimeter-wave radiation to date, with a detection limit of 1 mW. We examine the beam penetration, absorption and thermal diffusion at representative 4G and 5G frequencies and show that the RF heating increases rapidly with frequency due to decreasing RF source wavelength and increasing power density with the same incident power and exposure time. We also show the temperature effects of continuous wave, rapid pulse sequences and single pulses with varying pulse duration, and we employ electromagnetic modeling to map the field distributions in the tissue. Finally, using this new methodology, we measure the thermal diffusivity of ex vivo bovine brain tissue experimentally

A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.

Rosette-forming glioneuronal tumor (RGNT) most commonly occurs adjacent to the fourth ventricle and therefore rarely presents with epilepsy. Recent reports describe RGNT occurrence in other anatomical locations with considerable morphologic and genetic overlap with the epilepsy-associated dysembryoplastic neuroepithelial tumor (DNET). Examples of RGNT or DNET with anaplastic change are rare, and typically occur in the setting of radiation treatment. We present the case of a 5-year-old girl with seizures, who underwent near total resection of a cystic temporal lobe lesion. Pathology showed morphologic and immunohistochemical features of RGNT, albeit with focally overlapping DNET-like patterns. Resections of residual or recurrent tumor were performed 1 year and 5 years after the initial resection, but no adjuvant radiation or chemotherapy was given. Ten years after the initial resection, surveillance imaging identified new and enhancing nodules, leading to another gross total resection. This specimen showed areas similar to the original tumor, but also high-grade foci with oligodendroglial morphology, increased cellularity, palisading necrosis, microvascular proliferation, and up to 13 mitotic figures per 10 high power fields. Ancillary studies the status by sequencing showed wild-type of the isocitrate dehydrogenase 1 (IDH1), IDH2, and human histone 3.3 (H3F3A) genes, and BRAF studies were negative for mutation or rearrangement. Fluorescence in situ hybridization (FISH) showed codeletion of 1p and 19q limited to the high-grade regions. By immunohistochemistry there was loss of nuclear alpha-thalassemia mental retardation syndrome, X-linked (ATRX) expression only in the high-grade region. Next-generation sequencing showed an fibroblast growth factor receptor receptor 1 (FGFR1) kinase domain internal tandem duplication in three resection specimens. ATRX mutation in the high-grade tumor was confirmed by sequencing which showed a frameshift mutation (p.R1427fs), while the apparent 1p/19q-codeletion by FISH was due to loss of chromosome arm 1p and only partial loss of 19q. Exceptional features of this case include the temporal lobe location, 1p/19q loss by FISH without true whole-arm codeletion, and anaplastic transformation associated with ATRX mutation without radiation or chemotherapy

On the radiative efficiencies, Eddington ratios, and duty cycles of luminous high-redshift quasars

We investigate the characteristic radiative efficiency \epsilon, Eddington ratio \lambda, and duty cycle P_0 of high-redshift active galactic nuclei (AGN), drawing on measurements of the AGN luminosity function at z=3-6 and, especially, on recent measurements of quasar clustering at z=3-4.5 from the Sloan Digital Sky Survey. The free parameters of our models are \epsilon, \lambda, and the normalization, scatter, and redshift evolution of the relation between black hole mass \mbh and halo virial velocity V_vir. We compute the luminosity function from the implied growth of the black hole mass function and the quasar correlation length from the bias of the host halos. We test our adopted formulae for the halo mass function and halo bias against measurements from the large N-body simulation developed by the MICE collaboration. The strong clustering of AGNs observed at z=3 and, especially, at z=4 implies that massive black holes reside in rare, massive dark matter halos. Reproducing the observed luminosity function then requires high efficiency \epsilon and/or low Eddington ratio \lambda, with a lower limit (based on 2\sigma agreement with the measured z=4 correlation length) \epsilon> 0.7\lambda/(1+0.7\lambda), implying \epsilon > 0.17 for \lambda > 0.25. Successful models predict high duty cycles, P_0~0.2, 0.5, and 0.9 at z=3.1, 4.5 and 6, respectively, and they require that the fraction of halo baryons locked in the central black hole is much larger than the locally observed value. The rapid drop in the abundance of the massive and rare host halos at z>7 implies a proportionally rapid decline in the number density of luminous quasars, much stronger than simple extrapolations of the z=3-6 luminosity function would predict. (abridged)Comment: Replaced with version accepted by ApJ. More detailed analysis including black hole mergers. Results unchange

Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan

Rapamycin, an inhibitor of the mechanistic target of rapamycin (mTOR), robustly extends the lifespan of model organisms including mice. We recently found that chronic treatment with rapamycin not only inhibits mTOR complex 1 (mTORC1), the canonical target of rapamycin, but also inhibits mTOR complex 2 (mTORC2) in vivo. While genetic evidence strongly suggests that inhibition of mTORC1 is sufficient to promote longevity, the impact of mTORC2 inhibition on mammalian longevity has not been assessed. RICTOR is a protein component of mTORC2 that is essential for its activity. We examined three different mouse models of Rictor loss: mice heterozygous for Rictor, mice lacking hepatic Rictor, and mice in which Rictor was inducibly deleted throughout the body in adult animals. Surprisingly, we find that depletion of RICTOR significantly decreases male, but not female, lifespan. While the mechanism by which RICTOR loss impairs male survival remains obscure, we find that the effect of RICTOR depletion on lifespan is independent of the role of hepatic mTORC2 in promoting glucose tolerance. Our results suggest that inhibition of mTORC2 signaling is detrimental to males, which may explain in part why interventions that decrease mTOR signaling show greater efficacy in females

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

There is increasing evidence that oncogenic transformation modifies the metabolic program of cells. A common alteration is the upregulation of glycolysis, and efforts to target glycolytic enzymes for anticancer therapy are under way. Here, we performed a genome-wide haploid genetic screen to identify resistance mechanisms to 3-bromopyruvate (3-BrPA), a drug candidate that inhibits glycolysis in a poorly understood fashion. We identified the SLC16A1 gene product, MCT1, as the main determinant of 3-BrPA sensitivity. MCT1 is necessary and sufficient for 3-BrPA uptake by cancer cells. Additionally, SLC16A1 mRNA levels are the best predictor of 3-BrPA sensitivity and are most elevated in glycolytic cancer cells. Furthermore, forced MCT1 expression in 3-BrPA–resistant cancer cells sensitizes tumor xenografts to 3-BrPA treatment in vivo. Our results identify a potential biomarker for 3-BrPA sensitivity and provide proof of concept that the selectivity of cancer-expressed transporters can be exploited for delivering toxic molecules to tumors.National Institutes of Health (U.S.) (NIH CA103866)Jane Coffin Childs Memorial Fund for Medical Research (Fellowship)National Science Foundation (U.S.) (Fellowship)Howard Hughes Medical Institute (Investigator

Cell-specific microarray profiling experiments reveal a comprehensive picture of gene expression in the C. elegans nervous system

A novel strategy for profiling Caenorhabditis elegans cells identifies transcripts highly enriched in either the embryonic or larval C. elegans nervous system, including 19 conserved transcripts of unknown function that are also expressed in the mammalian brain

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries